
EVENITY® is an anabolic treatment for women with osteoporosis after menopause at high risk for fracture. But you can call it a bone-building treatment. EVENITY® rapidly reduces spine fracture risk and builds new bone in 12 months.

SAPHNELO is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are on standard therapy. SAPHNELO is not indicated for severe active lupus nephritis or severe active central nervous system lupus.

Cimzia® is a drug that reduces the signs and symptoms of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis, and Crohn’s disease. It works to improve such symptoms as joint swelling, pain, fatigue, and morning stiffness.

KRYSTEXXA® (pegloticase) is a prescription medicine used in adults to help reduce the signs and symptoms of gout that are not controlled by other treatments.

BENLYSTA is used to treat active systemic lupus erythematosus. It significantly reduces lupus disease activity and has beneficial effects on the immune system, muscles, joints, and skin.

Actemra blocks the activity of a cytokine in the immune system called IL-6. An overabundance of IL-6 causes the overproduction of white blood cells that attach the body and joints, a large contributing factor in rheumatoid arthritis.

Remicade is an effective treatment for rheumatoid arthritis, psoriatic arthritis, and Crohn’s Disease. It is given simultaneously with methotrexate to provide quick relief from pain and swelling due to rheumatoid arthritis.

Rituxan can reduce the signs and symptoms of moderate to severe active rheumatoid arthritis in adults with used with prescription methotrexate. It has also been used to treat ANCA-vascultitis.

This medication is used for adults with moderate to severe rheumatoid arthritis. It is used in combination with methotrexate and is administered every 8 weeks.